metoclopramide has been researched along with Inflammation in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
Excerpt | Relevance | Reference |
---|---|---|
" Incidences of postoperative nausea and vomiting, number of patients requiring antiemetic rescue, and overall consumption of metoclopramide were lower in groups B and C than in group A (all P < ." | 5.27 | Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study. ( Cao, G; Lei, Y; Pei, F; Xie, J; Xu, H; Zhang, S, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xu, H | 1 |
Zhang, S | 1 |
Xie, J | 1 |
Lei, Y | 1 |
Cao, G | 1 |
Pei, F | 1 |
Sufka, KJ | 1 |
Giordano, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Repeat Dose Steroid to Prevent Pain Relapse After Total Knee Arthroplasty in Patients With High Pain Response - A Randomized Double-blind Placebo-controlled Trial[NCT05563155] | Phase 4 | 110 participants (Anticipated) | Interventional | 2021-11-01 | Recruiting | ||
Methylprednisolone Taper to Treat Delayed Post-Operative Recovery After Total Knee Arthroplasty: a Double-Blind Randomized Controlled Trial[NCT05113901] | Phase 4 | 4 participants (Actual) | Interventional | 2022-03-03 | Terminated (stopped due to Extremely low participation, decided to focus on similar study instead) | ||
Steroid Administration for Articular Fractures of the Elbow (SAFE Trial): A Randomized, Controlled Trial of Perioperative Glucocorticoids During Treatment of Intraarticular Elbow Fractures[NCT04738318] | Phase 4 | 3 participants (Actual) | Interventional | 2022-06-16 | Terminated (stopped due to Switched to observational study type.) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Adverse outcomes including infection, avascular necrosis, and 90-day readmission rates (NCT05113901)
Timeframe: within 90 days after initial total knee arthroplasty
Intervention | Participants (Count of Participants) |
---|---|
Methylprednisolone Taper | 0 |
Placebo Taper | 0 |
Manipulations under anesthesia (MUAs) following total knee arthroplasty surgery and treatment (NCT05113901)
Timeframe: within 90 days after initial total knee arthroplasty
Intervention | Participants (Count of Participants) |
---|---|
Methylprednisolone Taper | 0 |
Placebo Taper | 0 |
Single Assessment Numeric Evaluation (SANE), a single-question patient rating of 0-100, scoring their function to the area being treated. Zero represents a poor functional knee and 100 is the best functioning. (NCT05113901)
Timeframe: 6 weeks after treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 89.5 |
UCLA activity score, on a scale of 1 to 10 where 10 is the most active patient with examples of activities (NCT05113901)
Timeframe: 6 weeks after treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 5.25 |
VR-12: Assesses physical functioning, physical/ mental limitations. Scored as summary of mental and physical, measure in standard deviations. The scale range is 0 to 100, where a score of 100 represents the best physical and mental health and zero is the worst outcome. (NCT05113901)
Timeframe: 6 weeks after treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 50.28 |
Forgotten Joint Score (FJS) is a survey scored ranging from 0 to 100, where a high score indicates a high degree of a forgetting they have an artificial joint, which is an ideal outcome. (NCT05113901)
Timeframe: 6 weeks after treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 57.82 |
Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR), a survey given to patients standard of care containing 7 questions. The score ranges from 0 to 100 where zero represents total disability and 100 represents a perfect knee health. (NCT05113901)
Timeframe: 6 weeks after treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 72.12 |
Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR), a survey given to patients standard of care containing 7 questions. The score ranges from 0 to 100 where zero represents total disability and 100 represents a perfect knee health. (NCT05113901)
Timeframe: pre treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 50.04 |
Single Assessment Numeric Evaluation (SANE), a single-question patient rating of 0-100, scoring their function to the area being treated. Zero represents a poor functional knee and 100 is the best functioning. (NCT05113901)
Timeframe: pre treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 29.5 |
Veterans Rand 12-Item Health Survey (VR-12), a survey of 12 questions to measure health relating to patient's quality of life. Scored as summary of mental and physical, measure in standard deviations. The scale range is 0 to 100, where a score of 100 represents the best physical and mental health and zero is the worst outcome. (NCT05113901)
Timeframe: pre treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 38.73 |
Forgotten Joint Score (FJS) is a survey scored ranging from 0 to 100, where a high score indicates a high degree of a forgetting they have an artificial joint, which is an ideal outcome. (NCT05113901)
Timeframe: pre treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 91.67 |
UCLA activity score, on a scale of 1 to 10 where 10 is the most active patient with examples of activities (NCT05113901)
Timeframe: pre treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 4.25 |
"Knee society score (KSS); done standard of care on a scale of 0-100, where 100 means a more functional knee.~**Please note, the study was terminated early, only 4 subjects were enrolled and none were randomized to the placebo group. At 3 weeks post treatment, only 3 of the 4 subjects enrolled were still part of the study." (NCT05113901)
Timeframe: 3 weeks post treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 68.33 |
"Knee society score (KSS); done standard of care on a scale of 0-100, where 100 means a more functional knee.~**Please note, the study was terminated early, only 4 subjects were enrolled and none were randomized to the placebo group. This is a standard of care survey available on all subjects." (NCT05113901)
Timeframe: 6 weeks post treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 78.75 |
"Using daily defense and veterans pain rating scale (DVPRS) on a scale of 1 to 10, 10 being the worst.~Please note, only one patient made it to the 6 week post treatment mark of the 4 enrolled. The study was terminated and none of the patients were randomized to the placebo group. All other patients followed up but were not interested in continuing. No range could be provided given only one subject answered and completed this visit" (NCT05113901)
Timeframe: 6 weeks post treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 1.93 |
"Knee society score (KSS); done standard of care on a scale of 0-100, where 100 means a more functional knee~**Please note, the study was terminated early, only 4 subjects were enrolled and none were randomized to the placebo group." (NCT05113901)
Timeframe: pre treatment
Intervention | score on a scale (Mean) |
---|---|
Methylprednisolone Taper | 66.25 |
"Using Daily Visual Analogue Scale (VAS) pain score, which measures intensity of pain on a scale of 0 (no pain) to 10 (worst pain possible).~**Please note, this study was terminated early, only enrolling 4 patients, none were randomized to the placebo group." (NCT05113901)
Timeframe: Days 1 through 6 following treatment
Intervention | score on a scale (Mean) | |||||
---|---|---|---|---|---|---|
Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | |
Methylprednisolone Taper | 2.33 | 3 | 1.33 | 1.33 | 1.67 | 2.3 |
"Range of motion (ROM) from pre-treatment to six weeks following treatment. Patients started treatment after total knee replacement surgery and presented to clinic with at least one inclusion criteria to be enrolled. Range of motion in degrees is taken at each visit by a clinician (standard of care), starting at zero degrees (straight leg) to about 135 degrees. The ROM was documented as part of consenting and enrollment into study. Subjects returned to the office at 6 weeks post treatment where ROM was performed in a clinic setting once again and documented. ROM is done using a goniometer by a clinician in each clinic.~This study was terminated early, therefore of the 4 enrolled, zero were randomized to the placebo group. Only 1 of the four subjects completed the 6 weeks, however, ROM was captured on all as standard of care." (NCT05113901)
Timeframe: Baseline, Week 6 Following Treatment
Intervention | Range of Motion in Degrees (Mean) | |
---|---|---|
Pre treatment | Post treatment | |
Methylprednisolone Taper | 82.5 | 112 |
1 trial available for metoclopramide and Inflammation
Article | Year |
---|---|
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study.
Topics: Aged; Analgesics; Antiemetics; Arthroplasty, Replacement, Knee; Blood Glucose; C-Reactive Protein; D | 2018 |
1 other study available for metoclopramide and Inflammation
Article | Year |
---|---|
Analgesic effects of S and R isomers of the novel 5-HT3 receptor antagonists ADR-851 and ADR-882 in rats.
Topics: Analgesics; Animals; Behavior, Animal; Benzofurans; Bridged Bicyclo Compounds; Bridged Bicyclo Compo | 1991 |